농촌의학ㆍ지역보건 (Journal of agricultural medicine and community health)

한국농촌의학지역보건학회 (Korean Society for Rural Medicine and Community Health)
권호 표지
DOI QR코드

DOI QR Code

고혈압과 apolipoprotein E의 다형성

The Effect of Apolipoprotein E Polymorphism on Hypertension in Korean Adults

  • 최대경 (가천의학전문대학원 예방의학과) ;
  • 김금하 (가천의학전문대학원 내과) ;
  • 박상현 (제주대학교 의과대학 마취통증의학과) ;
  • 임정수 (가천의학전문대학원 예방의학과)
  • Choi, Dae-Kyung (Department of Preventive Medicine, Gachon Medical School) ;
  • Kim, Geum-Ha (Department of Internal Medicine, Gachon Medical School) ;
  • Park, Sang-Hyun (Department of Anesthesiology and Pain Medicine, Cheju National University School of Medicine) ;
  • Im, Jeong-Soo (Department of Preventive Medicine, Gachon Medical School)
  • 발행 : 2007.09.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: Apolipoprotein E has been one of the most thoroughly studied genetic polymorphisms, particularly for its effects on lipid profiles and coronary heart disease risk. This study investigated the relationship between the apolipoprotein E polymorphism and essential hypertension in a Korean population. Methods: The subjects (n=1,243) were participants in a population-based study in Incheon metropolitan City, Korea. The apolipoprotein E polymorphism was determined using a polymerase chain reaction method. Results: The frequencies of the genotypes did not differ significantly between the hypertensive groups (60.0% ε2 / ε2, 30.8% ε2 / ε3, 44.4% ε2 / ε4, 33.3% ε3 / ε3, 32.3% ε3 / ε4, and 15.4% ε4 / ε4; p=0.498). After adjusting for other risk factors, genotypes were not associated with hypertension(OR 5.74, 95% CI 0.81-40.76, ε2 / ε2 vs. ε3 / ε3; OR 0.94, 95% CI 0.60-1.47, ε2 / ε3 vs. ε3 / ε3; OR 1.21, 95% CI 0.30-4.89, ε2 / ε4 vs. ε3 / ε3; OR 0.79, 95% CI 0.56-1.13, ε3 / ε4 vs. ε3 / ε3; OR 0.29, 95% CI 0.06-1.45, ε4 / ε4 vs. ε3 / ε3). Conclusions: These findings suggest that the apolipoprotein E polymorphism is not associated with hypertension.

키워드

참고문헌

  1. 이태용. 고혈압의 역학과 한국인에서의 주요위험요인 I /고혈압. 심혈관질환 예방 및 관리 연구회 편. 2003
  2. 보건복지부, 한국보건사회연구원. 2005년도 국민건강.영양조사 개요 및 결과. 2006
  3. Fisher ND, Williams GH. Hypertensive vascular disease. In: Kasper DL Braunwald E. Fauci AS, editors. Harrison's Principles of Internal Medicine. 16th ed. New York, McGraw-Hill. 2005, pp1463-1481
  4. 서일. 고혈압. 예방의학 편찬위원회 편, 2004
  5. Eichner JE, Dunn ST, Perveen G, Thompson DM. Stewart KE. Stroehla BC. Apolipoprotein E polymorphism and cardiovascular disease: A HuGE Review. Am J Epidmiol 2002:155(6) :487-495 https://doi.org/10.1093/aje/155.6.487
  6. Shin MH. Kim HN, Cui LH. Kweon SS. Park KS, Heo H, Nam HS, Jeong SK, Chung EK, Choi JS. The Effect of apolipoprotein E polymorphism on lipid levels in Korean adults. J Korean Med Sci 2005:20(3):361-366 https://doi.org/10.3346/jkms.2005.20.3.361
  7. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplication and clevage with HhaI. J Lipid Res 1990: 31: 545-548
  8. Eichner JE, Ferrell RE, Kamboh MI. Kuller LH, Becker DJ, Drash AL, Stein EA, Orchard TJ. The impact of the apolipoprotein E polymorphism on the lipoprotein profile in insulin-dependent diabetes: the Pittsburgh Epidemiology of Diabetes Complication Study IX. Metabolism 1992:41(4) :347-351 https://doi.org/10.1016/0026-0495(92)90066-J
  9. Eto M, Watanabe K, Makino I, Ishii K, Apolipoprotein E allele frequencies in non-insulin-dependent diabetes mellitus with hypertriglyceridemia. Metabolism 1991:40(8):776-780 https://doi.org/10.1016/0026-0495(91)90002-E
  10. Chowdhury TA, Dyer PH, Kumar S, Gibson SP, Rowe BR, Davies SJ, Marshall SM, Morris PJ, Gill GV, Feeney S , Maxwell P , Savage D, Boulton AJ, Todd JA, Dunger D, Barnett AH, Bain SC. Association of apolipoprotein ${\varepsilon}2$ allle with diabetic nephropathy in Caucasian subjects with IDDM. Diabetes 1998:47(2) :278-280 https://doi.org/10.2337/diab.47.2.278
  11. Economou-Petersen E, Aessopos A, Kladi A, Flevari P, Karabatsos F, Fragodimitri C, Nicolaidis P, Vrettou H, Vassilopoulos D, Karagiorga-Lagana M, Kremastinos DT, Petersen MB. Apolipoprotein ${\varepsilon}$4 allle as genetic risk factor for left ventricular failure in homozygous beta-halassemia. Blood 1998:92(9):3455-3459
  12. Hasegawa H, Nishi S, Ito S, Saeki T, Kuroda T, Kimura H, Watanabe T, Nakano M, Gejyo F, Arakawa M. High prevalence of serum apolipoprotein E4 isoprotein in rheumatoid arthritis patients with amyloidosis. (Comment). Arthritis Rheum 1998:41(7) :1328-1329
  13. Roses AD. Apolipoprotein E and Alzheimer's disease: the tip of the susceptibility iceberg. Ann N Y Acad Sci 1998: 855 :738-743 https://doi.org/10.1111/j.1749-6632.1998.tb10653.x
  14. Inzelberg R, Chapman J, Treves TA, Asherov A, Kipervasser S, Hilkewicz O, Verchovsky R, Klimowitzky S, Korczyn AD. Apolipoprotein E4 in Parkinson disease and dementia: new data and meta-analysis of published studies. Alzhemer Dis Assoc Disord 1998:12(1) :45-48 https://doi.org/10.1097/00002093-199803000-00007
  15. Chen JY, Hong CJ, Chiu HJ, Lin CY, Bai YM, Song HL, Lai HC, Tsai SJ. Apolipoprotein E genotype and schizophrenia. Neuropsychobiology 1999:39(3):141-143 https://doi.org/10.1159/000026573
  16. Forsell Y, Basun H, Corder EH, Lannfelt L , Winblad B. Psychotic symptoms and apolipoprotein E genotypes in an elderly population. Bio Psychiatry 1998:44(2) :139-140 https://doi.org/10.1016/S0006-3223(97)00352-1
  17. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr , Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute, National High Blood Pressure Education Program Coordinating Committee. Seven report of the joint national committee on the prevention, detection, evaluation and treatment of high blood pressure. Hypertension 2003:42:1206-1252 https://doi.org/10.1161/01.HYP.0000107251.49515.c2
  18. Jee SH, Appel LJ, Suh I, Whelton PK, Kim IS. Prevalence of cardiovascular risk factors in South Korea Medical Insurance Corporation(KMIC) Study. Ann Epidemiol 1998: 8(1) :14-21 https://doi.org/10.1016/S1047-2797(97)00131-2
  19. Ward R. Familial aggregation and genetic epidemiology of blood pressure. In hypertension: Pathophysiology, Diagnosis, and Management. JH Laragh and BM Brenner, eds. New York, Raven Press, 1990, pp81-100
  20. Suh I, Nam CM, Kim SJ, Shin D, Hur NW, Kang DR. Association analysis of the essential hypertension susceptibility genes in adolesecnts: Kangwha Study. J Prey Med Public Health 2006: 39(2) :177-183(Korean)
  21. Liu Y, Qiu C, Zhou W, Zheng Y, Hou S, Cao J. Gene polymophisms of the renin - angiotensin system in essential hypertension. Chin Med J 1999:112(2):115-120
  22. Giner V, Corella D, Javier Chaves F, Maria Pascual J, Portoles O, Marin P, Vicente Lozano J, Eugenia Armengod M, Redon J. Renin-angiotensin system genetic polymorphisms and essential hypertension in the Spanish. Med Clin 2001:117(14):525-529 https://doi.org/10.1016/S0025-7753(01)72167-7
  23. Porto PI, Garcia SI, Dieuzeide G, Gonzalez C, Pirola CJ. Renin-angiotensin-aldosterone system loci and multilocus interactions in young onset essential hypertension. Clin Exp Hypertens 2003:25(2):117-130 https://doi.org/10.1081/CEH-120017932
  24. Fabris B, Bortoletto M, Candido R, Barbone F, Cattin MR, Calci M, Scanferla F , Tizzoni L, Giacca M, Carretta R. Genetic polymorphisms of the renin-angiotensin-aldosterone system and renal insufficiency in essential hypertension. J Hypertens 2005:23(2):309-316 https://doi.org/10.1097/00004872-200502000-00013
  25. Kumar NN, Benjafield AV, Lin RC, Wang WY, Stowasser M, Morris BJ. Haplotype analysis of aldosterone synthase gene(CYP11B2) polymorphisms shows association with essential hypertension. J Hypertens 2003:21(7):1331-1337 https://doi.org/10.1097/00004872-200307000-00022
  26. Matsubara M, Omori F , Fujita S, Metoki H, Kikuya M, Fujiwara T, Araki T, Imai Y. Haplotypes of aldosterone synthase(CYP11B2) gene in the general population of Japan: the Ohasama study. Clin Exp Hypertens 2001:23(8):603-610 https://doi.org/10.1081/CEH-100107390
  27. Li B, Ge D, Wang Y, Zhao W, Zhou X, Gu D, Chen R. G protein beta3 subunit gene variants and essential hypertension in the northern Chinese Han population. Ann Hum Genet 2005:69(4):468-473 https://doi.org/10.1111/j.1529-8817.2005.00172.x
  28. Shioji K, Kokubo Y, Mannami T, Inamoto N, Morisaki H, Mino Y, Tagoi N, Yasui N, Iwaii N. Associations between hypertension and the alphaadducin, beta1-adrenoreceptor, and G protein beta3 subunit genes in the Japanese population: the Suita study. Hypertens Res 2004:27 (1) :31-37 https://doi.org/10.1291/hypres.27.31
  29. Katsuya T, Ishikawa K, Sugimoto K, Rakugi H, Ogihara T. Salt sensitivity of Japanese from the viewpoint of gene polymorphism. Hypertens Res 2003:26(7):521-525 https://doi.org/10.1291/hypres.26.521
  30. Shin MH, Chung EK, Kim HM, Park KS, Nam HS, Kweon SS, Choi JS. Alpha-adducin Gly460Trp Polymorphism and essential hypertension in Korea. J Korean Med Sci 2004:19(6) :812-814 https://doi.org/10.3346/jkms.2004.19.6.812
  31. 지선하. 심혈관질환과 인간유전체. 심혈관질환 및 예방 관리 연구회 편, 2003